Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Infliximab

Lupus-like reaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gibson M, et al. Safety and Durability of Accelerated Infliximab Dosing Strategies in Pediatric IBD: A Single Center, Retrospective Study. Journal of Pediatric Gastroenterology and Nutrition 77: 207-213, No. 2, Aug 2023. Available from: URL: http://journals.lww.com/jpgn Gibson M, et al. Safety and Durability of Accelerated Infliximab Dosing Strategies in Pediatric IBD: A Single Center, Retrospective Study. Journal of Pediatric Gastroenterology and Nutrition 77: 207-213, No. 2, Aug 2023. Available from: URL: http://​journals.​lww.​com/​jpgn
Metadaten
Titel
Infliximab
Lupus-like reaction: case report
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-48406-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Warfarin

Case report

Paclitaxel

Case report

Panobinostat

Case report

Retinol

Case report

Furosemide